Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada,
Curr Infect Dis Rep. 2010 Jul;12(4):282-90. doi: 10.1007/s11908-010-0105-4.
The consistency with which Mycoplasma pneumoniae has been implicated as a cause of encephalitis, and the increased incidence of central nervous system (CNS) disease observed during M. pneumoniae respiratory outbreaks, support the role of M. pneumoniae as a CNS pathogen. Three pathophysiologic mechanisms have been proposed: direct infection, autoimmunity, and vascular occlusion. Recent evidence demonstrating the organism's ability to survive intracellularly, presence of its DNA in the serum of individuals with acute encephalitis, case reports in which the organism is detected in brain parenchyma or cerebrospinal fluid (CSF), and animal data demonstrating CNS invasion by several Mycoplasma species support the contention that M. pneumoniae is capable of direct infection of the CNS. Because of limitations of current serologic assays and difficulty in interpreting the significance of positive polymerase chain reaction results in regard to acuity of infection and viability of the organism, the diagnosis of M. pneumoniae-associated CNS disease should be based on a combination of positive tests and exclusion of alternative diagnoses.
肺炎支原体一直被认为是脑炎的病因之一,并且在肺炎支原体呼吸道爆发期间观察到中枢神经系统 (CNS) 疾病的发病率增加,这支持了肺炎支原体作为 CNS 病原体的作用。有三种病理生理机制被提出:直接感染、自身免疫和血管阻塞。最近的证据表明该病原体能够在细胞内生存,其 DNA 存在于急性脑炎患者的血清中,在脑组织或脑脊液 (CSF) 中检测到该病原体的病例报告,以及动物数据表明几种支原体物种能够侵犯中枢神经系统,这些都支持肺炎支原体能够直接感染中枢神经系统的观点。由于目前血清学检测的局限性以及难以解释聚合酶链反应阳性结果在感染急性期和病原体活力方面的意义,肺炎支原体相关 CNS 疾病的诊断应基于阳性检测结果的组合,并排除其他诊断。